Moshirfar Majid, Somani Shaan N., Patel Bhupendra C.
University of Utah/John Moran Eye Center; Hoopes Vision/HDR Research Center; Utah Lions Eye Bank
Northwestern University Feinberg School of Medicine
The advent of the femtosecond (FS) laser has revolutionized the field of laser refractive surgery. Since its inception in 2003, the FS laser has become integral to various procedures, including laser in situ keratomileuses (LASIK). It has paved the way for innovative approaches like FS lenticule extraction (FLEx). Introduced in 2007, FLEx distinguishes itself by relying solely on the femtosecond laser platform, a departure from LASIK, necessitating using 2 platforms. This streamlined approach reduces procedural time and has proven cost-effective for institutions. While LASIK involves the formation of a corneal flap and the subsequent photoablation of the corneal stroma, FLEx shares the initial step of forming a corneal flap but diverges in its approach. In FLEx, there is no ablation of the corneal stroma; instead, the procedure entails intrastromal dissection and extraction of a refractive lenticule. This unique method offers a distinct advantage in refractive surgery, presenting a compelling alternative to traditional techniques. Small incision lenticule extraction (SMILE), an innovative laser refractive procedure, diverges from traditional methods by circumventing flap creation. Instead, it entails forming a small peripheral corneal incision to extract the lenticule. Sekundo et al, in 2008, initially described intrastromal lenticule extraction by lifting the flap akin to LASIK; however, this technique underwent modification to become SMILE, featuring the extraction of a refractive lenticule through a 2 mm small incision. The absence of corneal flap formation in SMILE was hypothesized to improve corneal biomechanical stability compared to LASIK or FLEx due to minimal disruption of the peripheral collagen networks in the anterior stroma, constituting approximately 60% of the total corneal tensile strength. Furthermore, the small incision of SMILE was theorized to reduce injury to the subbasal nerve plexus and avoid flap-related complications. Since its first use in 2008, SMILE has gained favor among ocular surgeons and holds the potential to emerge as the standard of care for surgically correcting visual refractive errors. SMILE has garnered recognition as being comparable to FS-LASIK in terms of efficacy, safety, and predictability, making it a preferred choice for the treatment of myopia and myopic astigmatism. The procedure delivers predictable and precise visual acuity and quality, increasing patient satisfaction. However, mastering the SMILE technique poses a steep learning curve for beginners. A step-wise approach is recommended to navigate this learning process effectively, involving observation, wet lab training, and experience with flap-based refractive lenticule extraction (such as FLEx and pseudo-SMILE). This structured learning path aids novice surgeons in comprehending the dynamics of SMILE surgery, mainly focusing on lamellar dissection and the handling of the refractive lenticule. Complications are more likely to arise during the initial learning phase, with the majority attributed to lenticule dissection and extraction challenges. As SMILE gains global popularity, various modifications to surgical techniques have been proposed to facilitate the process of lenticule dissection. The evolving landscape of SMILE surgery underscores the importance of ongoing innovation and refinement in surgical approaches to optimize learning outcomes and minimize complications for practitioners at all levels of expertise.
飞秒(FS)激光的出现彻底改变了激光屈光手术领域。自2003年问世以来,FS激光已成为包括准分子原位角膜磨镶术(LASIK)在内的各种手术不可或缺的一部分。它为诸如飞秒透镜切除术(FLEx)等创新方法铺平了道路。FLEx于2007年推出,其独特之处在于仅依赖飞秒激光平台,这与LASIK不同,LASIK需要使用两个平台。这种简化的方法减少了手术时间,并已被证明对医疗机构具有成本效益。虽然LASIK涉及制作角膜瓣以及随后对角膜基质进行光消融,但FLEx有制作角膜瓣的初始步骤,但其方法有所不同。在FLEx中,不进行角膜基质的消融;相反,该手术需要在基质内进行剥离并取出屈光透镜。这种独特的方法在屈光手术中具有明显优势,是传统技术的一个有吸引力的替代方案。小切口透镜切除术(SMILE)是一种创新的激光屈光手术,它与传统方法不同之处在于无需制作角膜瓣。相反,它需要制作一个小的周边角膜切口来取出透镜。Sekundo等人在2008年最初描述了通过像LASIK那样掀起角膜瓣来进行基质内透镜切除术;然而,该技术经过改进后成为SMILE,其特点是通过一个2毫米的小切口取出屈光透镜。与LASIK或FLEx相比,SMILE中不制作角膜瓣被认为可以提高角膜生物力学稳定性,因为前基质中的周边胶原网络受到的破坏最小,而周边胶原网络约占角膜总抗张强度的60%。此外,SMILE的小切口理论上可以减少对基底神经丛的损伤并避免与角膜瓣相关的并发症。自2008年首次使用以来,SMILE已受到眼科医生的青睐,并有可能成为手术矫正视觉屈光不正的标准治疗方法。SMILE在疗效、安全性和可预测性方面已获得认可,可与FS-LASIK相媲美,使其成为治疗近视和近视散光的首选。该手术可提供可预测且精确的视力和视觉质量,提高患者满意度。然而,对于初学者来说,掌握SMILE技术存在陡峭的学习曲线。建议采用逐步方法有效地应对这个学习过程,包括观察、湿实验室训练以及进行基于角膜瓣的屈光透镜切除术(如FLEx和伪SMILE)的经验。这种结构化的学习路径有助于新手外科医生理解SMILE手术的动态过程,主要侧重于板层剥离和屈光透镜的处理。在初始学习阶段更容易出现并发症,大多数并发症归因于透镜剥离和取出方面的挑战。随着SMILE在全球范围内越来越受欢迎,人们提出了各种手术技术改进方法以促进透镜剥离过程。SMILE手术不断发展的形势凸显了持续创新和改进手术方法的重要性,以便为各级专业水平的从业者优化学习成果并尽量减少并发症。